Covered recipient · General Payments record
JOSEPH RUSSELL WILLIAMS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$173.27
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141.36 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $32.15 | 2 |
| Amgen Inc. | $22.01 | 1 |
| Exact Sciences Corporation | $21.84 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.66 | 1 |
| Acerta Pharma LLC | $16.82 | 1 |
| Astellas Pharma US Inc | $15.79 | 1 |
| Genentech USA, Inc. | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.01 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111739830 | CMS |
| Astellas Pharma US Inc | $15.79 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139444690 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.82 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105508012 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.66 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117921653 | CMS |
| Exact Sciences Corporation | $21.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114950508 | CMS |
| Genentech USA, Inc. | $15.09 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133040753 | CMS |
| Novo Nordisk Inc | $14.86 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621434 | CMS |
| Novo Nordisk Inc | $17.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097548818 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.